Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |